The emerging role of triple helices in RNA biology

Wiley Interdisciplinary Reviews: RNA

Volumn 5, Issue 1, 2014, Pages 15-29

  Conrad, Nicholas K ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MALAT1 PROTEIN; MEMBRANE PROTEIN; NUCLEAR RNA; POLYADENYLATED RNA; POLYADENYLIC ACID; RNA; S ADENOSYLMETHIONINE; TELOMERASE; TELOMERASE ASSOCIATED RNA; UNCLASSIFIED DRUG; UNTRANSLATED RNA; VIRUS RNA;

BINDING AFFINITY; BIOLOGICAL ACTIVITY; BIOLOGICAL FUNCTIONS; CYTOLOGY; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; NONHUMAN; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; REVIEW; RIBOSWITCH; RNA METABOLISM; RNA STABILITY; RNA STRUCTURE; RNA TRANSCRIPTION; RNA TRANSLATION; TRIPLE HELIX;

ANIMALS; BASE SEQUENCE; BINDING SITES; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; PROTEIN BIOSYNTHESIS; RIBOSWITCH; RNA;

EID: 84890278241     PISSN: 17577004     EISSN: 17577012     Source Type: Journal    
DOI: 10.1002/wrna.1194     Document Type: Review

References (83)

1. Cech TR. Structural biology. The ribosome is a ribozyme. Science 2000, 289:878-879.
2. Rich A, Felsenfeld G. Formation of a threestranded polynucleotide molecule. J Am Chem Soc 1957, 79:2023-2024.
3. Felsenfeld G, Rich A. Studies on the formation of two- and three-stranded polyribonucleotides. Biochim Biophys Acta 1957, 1000:87-98.
4. Buske FA, Mattick JS, Bailey TL. Potential in vivo roles of nucleic acid triple-helices. RNA Biol 2011, 8:427-439. doi: 10.4161/rna.8.3.14999.
5. Rich A. Discovery of the hybrid helix and the first DNA-RNA hybridization. J Biol Chem 2006, 281:7693-7696. doi: 10.1074/JBC.X600003200.
6. Rich A. The era of RNA awakening: structural biology of RNA in the early years. Q Rev Biophys 2009, 42:117-137. doi: 10.1017/S0033583509004776.
7. Hoogsteen K. The crystal and molecular structure of a hydrogen-bonded complex between 1-methylthymine and 9-methyladenine. Acta Cryst 1963, 16:907-916. doi: 10.1107/S0365110X63002437.
8. Gilbert SD, Rambo RP, Van Tyne D, Batey RT. Structure of the SAM-II riboswitch bound to S-adenosylmethionine. Nat Struct Mol Biol 2008, 15:177-182. doi: 10.1038/nsmb.1371.
9. Theimer CA, Blois CA, Feigon J. Structure of the human telomerase RNA pseudoknot reveals conserved tertiary interactions essential for function. Mol Cell 2005, 17:671-682. doi: 10.1016/j.molcel.2005.01.017.
10. Chastain M, Tinoco I. Nucleoside triples from the group I intron. Biochemistry 1993, 32:14220-14228.
11. Su L, Chen L, Egli M, Berger JM, Rich A. Minor groove RNA triplex in the crystal structure of a ribosomal frameshifting viral pseudoknot. Nat Struct Biol. 1999, 6:285-292. doi: 10.1038/6722.
12. Mitton-Fry RM, DeGregorio SJ, Wang J, Steitz TA, Steitz JA. Poly(A) tail recognition by a viral RNA element through assembly of a triple helix. Science 2010, 330:1244-1247. doi: 10.1126/science.1195858.
13. Toor N, Keating KS, Taylor SD, Pyle AM. Crystal structure of a self-spliced group II intron. Science 2008, 320:77-82. doi: 10.1126/science.1153803.
14. Wilusz JE, JnBaptiste CK, Lu LY, Kuhn CD, Joshua-Tor L, Sharp PA. A triple helix stabilizes the 3' ends of long noncoding RNAs that lack poly(A) tails. Genes Dev 2012, 26:2392-2407. doi: 10.1101/gad.204438.112.
15. Chastain M, Tinoco I. A base-triple structural domain in RNA. Biochemistry 1992, 31:12733-12741.
16. Serganov A, Nudler E. A decade of riboswitches. Cell 2013, 152(1-2):17-24. doi: 10.1016/j.cell.2012.12.024.
17. Roje S. S-Adenosyl-L-methionine: beyond the universal methyl group donor. Phytochemistry 2006, 67:1686-1698. doi: 10.1016/j.phytochem.2006.04.019.
18. Wang JX, Breaker RR. Riboswitches that sense S-adenosylmethionine and S-adenosylhomocysteine. Biochem Cell Biol 2008, 86:157-168. doi: 10.1139/O08-008.
19. Poiata E, Meyer MM, Ames TD, Breaker RR. A variant riboswitch aptamer class for S-adenosylmethionine common in marine bacteria. RNA 2009, 15:2046-2056. doi: 10.1261/rna.1824209.
20. Weinberg Z, Regulski EE, Hammond MC, Barrick JE, Yao Z, Ruzzo WL, Breaker RR. The aptamer core of SAM-IV riboswitches mimics the ligand-binding site of SAM-I riboswitches. RNA 2008, 14:822-828. doi: 10.1261/rna.988608.
21. Parker BJ, Moltke I, Roth A, Washietl S, Wen J, Kellis M, Breaker R, Pedersen JS. New families of human regulatory RNA structures identified by comparative analysis of vertebrate genomes. Genome Res 2011, 21:1929-1943. doi: 10.1101/gr.112516.110.
22. Corbino KA, Barrick JE, Lim J, Welz R, Tucker BJ, Puskarz I, Mandal M, Rudnick ND, Breaker RR. Evidence for a second class of S-adenosylmethionine riboswitches and other regulatory RNA motifs in alpha-proteobacteria. Genome Biol 2005, 6:R70. doi: 10.1186/gb-2005-6-8-r70.
23. Doshi U, Kelley JM, Hamelberg D. Atomic-level insights into metabolite recognition and specificity of the SAM-II riboswitch. RNA 2012, 18:300-307. doi: 10.1261/rna.028779.111.
24. Haller A, Rieder U, Aigner M, Blanchard SC, Micura R. Conformational capture of the SAM-II riboswitch. Nat Chem Biol 2011, 7:393-400. doi: 10.1038/nchembio.562.
25. Chen B, Zuo X, Wang Y-X, Dayie TK. Multiple conformations of SAM-II riboswitch detected with SAXS and NMR spectroscopy. Nucleic Acids Res 2012, 40:3117-3130. doi: 10.1093/nar/gkr1154.
26. Kelley JM, Hamelberg D. Atomistic basis for the on-off signaling mechanism in SAM-II riboswitch. Nucleic Acids Res 2010, 38:1392-1400. doi: 10.1093/nar/gkp1106.
27. Blackburn EH, Collins K. Telomerase: an RNP enzyme synthesizes DNA. Cold Spring Harb Perspect Biol 2011, 3:a003558-a003558. doi: 10.1101/cshperspect.a003558.
28. Shay JW, Wright WE. Role of telomeres and telomerase in cancer. Semin Cancer Biol 2011, 21:349-353. doi: 10.1016/j.semcancer.2011.10.001.
29. Günes C, Rudolph KL. The role of telomeres in stem cells and cancer. Cell 2013, 152:390-393. doi: 10.1016/j.cell.2013.01.010.
30. Wyatt HDM, West SC, Beattie TL. InTERTpreting telomerase structure and function. Nucleic Acids Res 2010, 38:5609-5622. doi: 10.1093/nar/gkq370.
31. Gillis AJ, Schuller AP, Skordalakes E. Structure of the Tribolium castaneum telomerase catalytic subunit TERT. Nature 2008, 455:633-637. doi: 10.1038/nature07283.
32. Kim N-K, Zhang Q, Zhou J, Theimer CA, Peterson RD, Feigon J. Solution structure and dynamics of the wild-type pseudoknot of human telomerase RNA. J Mol Biol 2008, 384:1249-1261. doi: 10.1016/j.jmb.2008.10.005.
33. Egan ED, Collins K. Biogenesis of telomerase ribonucleoproteins. RNA 2012, 18:1747-1759. doi: 10.1261/rna.034629.112.
34. Chen JL, Blasco MA, Greider CW. Secondary structure of vertebrate telomerase RNA. Cell 2000, 100:503-514.
35. Chen J-L, Greider CW. An emerging consensus for telomerase RNA structure. Proc Natl Acad Sci USA 2004, 101:14683-14684. doi: 10.1073/pnas.0406204101.
36. Theimer CA, Feigon J. Structure and function of telomerase RNA. Curr Opin Struct Biol 2006, 16:307-318. doi: 10.1016/j.sbi.2006.05.005.
37. Qiao F, Cech TR. Triple-helix structure in telomerase RNA contributes to catalysis. Nat Struct Mol Biol 2008, 15:634-640. doi: 10.1038/nsmb.1420.
38. Shefer K, Brown Y, Gorkovoy V, Nussbaum T, Ulyanov NB, Tzfati Y. A triple helix within a pseudoknot is a conserved and essential element of telomerase RNA. Mol Cell Biol 2007, 27:2130-2143. doi: 10.1128/MCB.01826-06.
39. Huang C, Yu Y-T. Targeted 2'-O methylation at a nucleotide within the pseudoknot of telomerase RNA reduces telomerase activity in vivo. Mol Cell Biol 2010, 30:4368-4378. doi: 10.1128/MCB.00384-10.
40. Liu F, Theimer CA. Telomerase activity is sensitive to subtle perturbations of the TLC1 pseudoknot 3' stem and tertiary structure. J Mol Biol 2012, 423:719-735. doi: 10.1016/j.jmb.2012.08.025.
41. Mesri EA, Cesarman E, Boshoff C. Kaposi's sarcoma and its associated herpesvirus. Nat Rev Cancer 2010, 10:707-719. doi: 10.1038/nrc2888.
42. Cai Q, Verma SC, Lu J, Robertson ES. Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis. Adv Virus Res 2010, 78:87-142. doi: 10.1016/B978-0-12-385032-4.00003-3.
43. Wen KW, Damania B. Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis. Cancer Lett 2010, 289:140-150. doi: 10.1016/j.canlet.2009.07.004.
44. Song MJ, Brown HJ, Wu TT, Sun R. Transcription activation of polyadenylated nuclear RNA by RTA in human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus. J Virol 2001, 75:3129-3140. doi: 10.1128/JVI.75.7.3129-3140.2001.
45. Sun R, Lin SF, Gradoville L, Miller G. Polyadenylylated nuclear RNA encoded by Kaposi sarcoma-associated herpesvirus. Proc Natl Acad Sci USA 1996, 93:11883-11888.
46. Zhong W, Wang H, Herndier B, Ganem D. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc Natl Acad Sci USA 1996, 93:6641-6646.
47. Rossetto CC, Pari G. KSHV PAN RNA associates with demethylases UTX and JMJD3 to activate lytic replication through a physical interaction with the virus genome. PLoS Pathog 2012, 8:e1002680. doi: 10.1371/journal.ppat.1002680.t002.
48. Borah S, Darricarrère N, Darnell A, Myoung J, Steitz JA. A viral nuclear noncoding rna binds re-localized poly(A) binding protein and is required for late KSHV gene expression. PLoS Pathog 2011, 7:e1002300. doi: 10.1371/journal.ppat.1002300.g009.
49. Rossetto CC, Pari GS. KSHV noncoding PAN RNA interacts with virus and cellular-encoded proteins and suppresses expression of genes involved in immune modulation. J Virol 2011. doi: 10.1128/JVI.05886-11.
50. Rossetto CC, Tarrant-Elorza M, Verma S, Purushothaman P, Pari GS. Regulation of viral and cellular gene expression by Kaposi's sarcoma associated herpesvirus (KSHV) PAN RNA. J Virol 2013. doi: 10.1128/JVI.03111-12.
51. Shamovsky I, Nudler E. Gene control by large noncoding RNAs. Sci STKE 2006, 2006:pe40. doi: 10.1126/stke.3552006pe40.
52. Batista PJ, Chang HY. Long noncoding RNAs: cellular address codes in development and disease. Cell 2013, 152:1298-1307. doi: 10.1016/j.cell.2013.02.012.
53. Conrad NK, Steitz JA. A Kaposi's sarcoma virus RNA element that increases the nuclear abundance of intronless transcripts. EMBO J 2005, 24:1831-1841. doi: 10.1038/sj.emboj.7600662.
54. Conrad NK, Shu M-D, Uyhazi KE, Steitz JA. Mutational analysis of a viral RNA element that counteracts rapid RNA decay by interaction with the polyadenylate tail. Proc Natl Acad Sci USA 2007, 104:10412-10417. doi: 10.1073/pnas.0704187104.
55. Conrad NK, Mili S, Marshall EL, Shu M-D, Steitz JA. Identification of a rapid mammalian deadenylation-dependent decay pathway and its inhibition by a viral RNA element. Mol Cell 2006, 24:943-953. doi: 10.1016/j.molcel.2006.10.029.
56. Schmid M, Jensen TH. Quality control of mRNP in the nucleus. Chromosoma 2008, 117:419-429. doi: 10.1007/s00412-008-0166-4.
57. Fasken MB, Corbett AH. Mechanisms of nuclear mRNA quality control. RNA Biol 2009, 6:237-241.
58. Doma MK, Parker R. RNA quality control in eukaryotes. Cell 2007, 131:660-668. doi: 10.1016/j.cell.2007.10.041.
59. Doherty EA, Batey RT, Masquida B, Doudna JA. A universal mode of helix packing in RNA. Nat Struct Biol 2001, 8:339-343. doi: 10.1038/86221.
60. Nissen P, Ippolito JA, Ban N, Moore PB, Steitz TA. RNA tertiary interactions in the large ribosomal subunit: the A-minor motif. Proc Natl Acad Sci USA 2001, 98:4899-4903. doi: 10.1073/pnas.081082398.
61. Tycowski KT, Shu M-D, Borah S, Shi M, Steitz JA. Conservation of a triple-helix-forming RNA stability element in noncoding and genomic RNAs of diverse viruses. CellReports 2012, 2:26-32. doi: 10.1016/j.celrep.2012.05.020.
62. La Scola B, Audic S, Robert C, Jungang L, de Lamballerie X, Drancourt M, Birtles R, Claverie J-M, Raoult D. A giant virus in amoebae. Science 2003, 299:2033. doi: 10.1126/science.1081867.
63. Bonning BC, Miller WA. Dicistroviruses. Annu Rev Entomol 2010, 55:129-150. doi: 10.1146/annurev-ento-112408-085457.
64. Brown JA, Valenstein ML, Yario TA, Tycowski KT, Steitz JA. Formation of triple-helical structures by the 3'-end sequences of MALAT1 and MENβ noncoding RNAs. Proc Natl Acad Sci 2012. doi: 10.1073/pnas.1217338109.
65. Ji P, Diederichs S, Wang W, Böing S, Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003, 22:8031-8041. doi: 10.1038/sj.onc.1206928.
66. Gutschner T, Hämmerle M, Diederichs S. MALAT1-a paradigm for long noncoding RNA function in cancer. J Mol Med 2013. doi: 10.1007/s00109-013-1028-y.
67. Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, Freier SM, Bennett CF, Sharma A, Bubulya PA, et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell 2010, 39:1-14. doi: 10.1016/j.molcel.2010.08.011.
68. Tripathi V, Shen Z, Chakraborty A, Giri S, Freier SM, Wu X, Zhang Y, Gorospe M, Prasanth SG, Lal A, et al. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet 2013, 9:e1003368. doi: 10.1371/journal.pgen.1003368.
69. Yang L, Lin C, Liu W, Zhang J, Ohgi KA, Grinstein JD, Dorrestein PC, Rosenfeld MG. ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs. Cell 2011, 147:773-788. doi: 10.1016/j.cell.2011.08.054.
70. Eißmann M, Gutschner T, Hämmerle M, Günther S, Caudron-Herger M, Groß M, Schirmacher P, Rippe K, Braun T, Zörnig M, et al. Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development. RNA Biol 2012, 9:1076-1087. doi: 10.4161/rna.21089.
71. Zhang B, Arun G, Mao YS, Lazar Z, Hung G, Bhattacharjee G, Xiao X, Booth CJ, Wu J, Zhang C, et al. The lncRNA Malat1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult. CellReports 2012, 2:111-123. doi: 10.1016/j.celrep.2012.06.003.
72. Nakagawa S, Ip JY, Shioi G, Tripathi V, Zong X, Hirose T, Prasanth KV. Malat1 is not an essential component of nuclear speckles in mice. RNA 2012, 18:1487-1499. doi: 10.1261/rna.033217.112.
73. Wilusz JE, Freier SM, Spector DL. 3' end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA. Cell 2008, 135:919-932. doi: 10.1016/j.cell.2008.10.012.
74. Wilusz JE, Spector DL. An unexpected ending: noncanonical 3' end processing mechanisms. RNA 2010, 16:259-266. doi: 10.1261/rna.1907510.
75. Pijlman GP, Funk A, Kondratieva N, Leung J, Torres S, van der Aa L, Liu WJ, Palmenberg AC, Shi P-Y, Hall RA, et al. A highly structured, nuclease-resistant, noncoding RNA produced by flaviviruses is required for pathogenicity. Cell Host Microbe 2008, 4:579-591. doi: 10.1016/j.chom.2008.10.007.
76. Mullen TE, Marzluff WF. Degradation of histone mRNA requires oligouridylation followed by decapping and simultaneous degradation of the mRNA both 5' to 3' and 3' to 5'. Genes Dev 2008, 22:50-65. doi: 10.1101/gad.1622708.
77. Scott DD, Norbury CJ. RNA decay via 3' uridylation. Biochim Biophys Acta 2013. doi: 10.1016/j.bbagrm.2013.01.009.
78. Anderson JT. RNA turnover: unexpected consequences of being tailed. Curr Biol 2005, 15:R635-8. doi: 10.1016/j.cub.2005.08.002.
79. Kühn U, Wahle E. Structure and function of poly(A) binding proteins. Biochim Biophys Acta 2004, 1678(2-3):67-84. doi: 10.1016/j.bbaexp.2004.03.008.
80. Galindo MI, Pueyo JI, Fouix S, Bishop SA, Couso JP. Peptides encoded by short ORFs control development and define a new eukaryotic gene family. PLoS Biol 2007, 5:e106. doi: 10.1371/journal.pbio.0050106.
81. Ingolia NT, Lareau LF, Weissman JS. Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes. Cell 2011, 147:789-802. doi: 10.1016/j.cell.2011.10.002.
82. Xu Y, Ganem D. Making sense of antisense: seemingly noncoding RNAs antisense to the master regulator of Kaposi's sarcoma-associated herpesvirus lytic replication do not regulate that transcript but serve as mRNAs encoding small peptides. J Virol 2010, 84:5465-5475. doi: 10.1128/JVI.02705-09.
83. Keating KS, Toor N, Perlman PS, Pyle AM. A structural analysis of the group II intron active site and implications for the spliceosome. RNA 2009, 16:1-9. doi: 10.1261/rna.1791310.